Novan Announces $6.0 Million Registered Direct Offering
14 mars 2023 08h00 HE
|
Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has entered into definitive agreements for the issuance and sale in a...
Novan Moves Forward with Unified Corporate Branding
08 mars 2023 09h00 HE
|
Novan, Inc.
– Novan is a fully integrated pharmaceutical company with proven capabilities across drug development through to commercialization – – EPI Health adopts Novan corporate branding, creating unified...
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
07 mars 2023 08h00 HE
|
Novan, Inc.
– FDA completes filing review of application with no filing issues identified – – New Chemical Entity (“NCE”) has potential to be the first FDA-approved prescription product for molluscum in the...
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
18 janv. 2023 08h05 HE
|
Novan, Inc.
DURHAM, N.C., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will...
Stonewall Kitchen Announces New January 2023 Product Launch
09 janv. 2023 01h00 HE
|
Stonewall Kitchen
YORK, Maine, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Stonewall Kitchen and its family of brands are pleased to announce their new January product launch, which introduces over 50 new items into the...
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
06 janv. 2023 08h00 HE
|
Novan, Inc.
– Potential FDA approval anticipated in first quarter 2024, assuming the filing is accepted by the FDA and under standard review timelines – – Molluscum contagiosum is a viral skin infection that...
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
21 déc. 2022 08h00 HE
|
Novan, Inc.
DURHAM, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that EPI Health, LLC, a fully consolidated subsidiary of Novan, has entered...
Konica Minolta lance l’AccurioShine 3600 avec iFoil One
14 déc. 2022 11h00 HE
|
Solutions d’affaires Konica Minolta (Canada) Ltée
MISSISSAUGA, Ontario, 14 déc. 2022 (GLOBE NEWSWIRE) -- Solutions d’affaires Konica Minolta (Canada) Ltée (Konica Minolta), chef de file des solutions d’impression et d’emballage industrielles...
Konica Minolta Launches AccurioShine 3600 + iFoil One
14 déc. 2022 11h00 HE
|
Konica Minolta Business Solutions (Canada) Ltd.
MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions (Canada) Ltd. (Konica Minolta), a leader in industrial and commercial printing and packaging solutions,...
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
02 déc. 2022 08h00 HE
|
Novan, Inc.
– Agreement provides immediate access to cash flow – – EPI Health leveraging accounts receivables from commercial product sales to bolster working capital needs – DURHAM, N.C., Dec. 02, 2022 ...